Autologous Skeletal Myoblast/Mononuclear Bone Marrow Cell Transplantation

Aetna considers autologous skeletal myoblast transplantation, autologous intra-coronary mononuclear bone marrow cell or cardiosphere-derived cell administration, and autologous/allogeneic bone marrow–derived mesenchymal stem cell transplantation experimental/investigational and therefore not covered for heart failure, myocardial infarction, other cardiac diseases, Duchenne muscular dystrophy, ankylosing spondylitis, cerebellar ataxia, and similar indications. The exclusion is based on lack of established effectiveness—no coverage is provided for these procedures for the listed conditions.

"No explicit covered indications are stated in this document."

Sign up to see full coverage criteria, indications, and limitations.